Personalized Medicine 8.0 (http://personalizedmedicine.sfsu.edu/), organized by San Francisco State University (SFSU) and its Biology Department Chairman Michael Goldman, Ph.D., will take place on Thursday, May 28, 2015, from 8:00 am to 6:00 pm at the South San Francisco Conference Center (http://www.ssfconf.com/directions-top), with a reception to follow. This year’s eighth annual event is entitled, “Genetic Screening & Predictive Medicine.” You may register for this one-day conference at http://personalizedmedicine.sfsu.edu. For additional registration information, academic and group rates, or to become a sponsor of Personalized Medicine 8.0, please contact dnamed@sfsu.edu. Early registration is $295; later registration is $495. The opening keynote address this year will be delivered by Rajesh Chopra, M.D., Ph.D., Corporate Vice President, Translational & Early Drug Development, Celgene, speaking on “Cancer: Predicting, Preventing, and Curing.” You may view the complete program at (http://personalizedmedicine.sfsu.edu/docs/pers_med_2015_program_singlepage.pdf). Among the other speakers will be Jeffrey D. Pollard, M.D., Director, Medical Affairs, 23andMe; Stephan Morris, M.D., Scientific Founder and CSO of Insight Genetics, Inc.; Tristan B. Orpin, Senior Vice President and General Manager, Reproductive and Genetic Health, Illumina, Inc.; Nicole Miller, Ph.D., Director, Global Scientific Affairs, BioMarin Pharmaceutical Inc.; and Karoly Nikolich, Ph.D., CEO, Alkahest, Inc. The closing keynote will be delivered by Matt R.Login Or Register To Read Full Story